Risk of major CV events on low- and high-intensity statin therapy1,*

Risk of major CV events on low- and high-intensity statin therapy over 6 years Risk of major CV events on low- and high-intensity statin therapy over 6 years

It’s time to bring down their risk of another MI or stroke

A total of 10,001 patients with patients with coronary heart disease and LDL-C of < 130 mg/dL were randomly assigned to either low-intensity or high-intensity statin therapy.

*The primary endpoint was the occurrence of a first major cardiovascular event, defined as death from CHD, nonfatal non-procedure-related myocardial infarction, resuscitation after cardiac arrest, or fatal or nonfatal stroke.1

CHD = coronary heart disease; HR = hazard ratio.